Markets
Companies See Fewer SEC Comments in Registration Process, Study Finds
|
Last year's IPOs may have had an easier time with Securities and Exchange Commission staff than in the previous two years.
News
Orexigen Raising $165M in Private Placement as Part of Contrave Deal
|
Investors led by Baupost Group are buying $165 million in convertible secured notes from Orexigen Therapeutics (OREX) to help fund the commercialization of Contrave as Orexigen buys the U.S. rights to the anti-obesity drug.
News
Avant, Amarantus Diagnostics Buying Theranostics
|
Avant Diagnostics, Amarantus BioScience Holdings' diagnostics unit and Theranostics Health Inc. are merging so that the two makers of medical tests can take advantage of Theranostics's sales channel.
Legal
California Rulings Prove Nettlesome to Issuers of Underperforming IPOs
|
State courts have been accepting some lawsuits from disappointed investors, despite legislation that was meant to keep securities suits in federal court.
